XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	3,120	3,160	14.11.

Realtime

Geld

Brief

Zeit

3,120

3,160

14.11.

XFRA CAPITAL ADJUSTMENT INFORMATION - 12.06.2025

Das Instrument W1E JE00BSBJ5M88 ROSEBANK INDS LS -,001 EQUITY wird ex Kapitalmassnahme gehandelt am 12.06.2025
The instrument W1E JE00BSBJ5M88 ROSEBANK INDS LS -,001 EQUITY is traded ex capital adjustment on 12.06.2025

Das Instrument UA5 NO0011018434 NORDIC TECH.GRP.NK-,00423 EQUITY wird ex Kapitalmassnahme gehandelt am 12.06.2025
The instrument UA5 NO0011018434 NORDIC TECH.GRP.NK-,00423 EQUITY is traded ex capital adjustment on 12.06.2025

Das Instrument RBG SE0000112252 ROTTNEROS AB FR. SK 1 EQUITY wird cum Kapitalmassnahme gehandelt am 12.06.2025 und ex Kapitalmassnahme am 13.06.2025
The instrument RBG SE0000112252 ROTTNEROS AB FR. SK 1 EQUITY is traded cum capital adjustment on 12.06.2025 and ex capital adjustment on 13.06.2025

Das Instrument 5IU SE0009581051 ISOFOL MEDICAL AB EQUITY wird cum Kapitalmassnahme gehandelt am 12.06.2025 und ex Kapitalmassnahme am 13.06.2025
The instrument 5IU SE0009581051 ISOFOL MEDICAL AB EQUITY is traded cum capital adjustment on 12.06.2025 and ex capital adjustment on 13.06.2025

Das Instrument R10 CA74061L1040 PREMIUM RES LTD. O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 12.06.2025 und ex Kapitalmassnahme am 13.06.2025
The instrument R10 CA74061L1040 PREMIUM RES LTD. O.N. EQUITY is traded cum capital adjustment on 12.06.2025 and ex capital adjustment on 13.06.2025

Das Instrument 2AI SE0013719077 QLIRO AB EQUITY wird cum Kapitalmassnahme gehandelt am 12.06.2025 und ex Kapitalmassnahme am 13.06.2025
The instrument 2AI SE0013719077 QLIRO AB EQUITY is traded cum capital adjustment on 12.06.2025 and ex capital adjustment on 13.06.2025

Zeit	Aktuelle Nachrichten
Do	Isofol Medical AB: European Patent Office intends to grant a new patent for Isofol's arfolitixorin	GOTHENBURG, Sweden, November 13 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the European Patent Office (EPO) has issued an Intention to Grant notice regarding a... ► Artikel lesen
Mi	Isofol Medical AB: Isofol Medical AB (publ) publishes interim report, January-September 2025	GOTHENBURG, Sweden, November 12, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), ("Isofol" or the "Company"), announced today that the company's interim report for January-September 2025... ► Artikel lesen
30.09.	Isofol Medical AB: Isofol's clinical study with arfolitixorin reaches another important milestone	GOTHENBURG, Sweden, September 30, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully completed the second dose level in the dose escalating... ► Artikel lesen
26.09.	Isofol Medical AB: Isofol completes transfer of shares to Solasia Pharma following a successful rights issue	GOTHENBURG, Sweden, September 26, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the transfer of the shares subscribed by the Japanese collaboration partner Solasia... ► Artikel lesen
26.08.	Isofol Medical AB: Isofol Medical AB (publ) publishes interim report, January-June 2025	GOTHENBURG, Sweden, August 26, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January-June 2025 is now available, in Swedish, on the... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Isofol Medical AB: European Patent Office intends to grant a new patent for Isofol's arfolitixorin

GOTHENBURG, Sweden, November 13 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the European Patent Office (EPO) has issued an Intention to Grant notice regarding a...
► Artikel lesen

Isofol Medical AB: Isofol Medical AB (publ) publishes interim report, January-September 2025

GOTHENBURG, Sweden, November 12, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), ("Isofol" or the "Company"), announced today that the company's interim report for January-September 2025...
► Artikel lesen

30.09.

Isofol Medical AB: Isofol's clinical study with arfolitixorin reaches another important milestone

GOTHENBURG, Sweden, September 30, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the company has successfully completed the second dose level in the dose escalating...
► Artikel lesen

26.09.

Isofol Medical AB: Isofol completes transfer of shares to Solasia Pharma following a successful rights issue

GOTHENBURG, Sweden, September 26, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announces today that the transfer of the shares subscribed by the Japanese collaboration partner Solasia...
► Artikel lesen

26.08.

Isofol Medical AB: Isofol Medical AB (publ) publishes interim report, January-June 2025

GOTHENBURG, Sweden, August 26, 2025 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January-June 2025 is now available, in Swedish, on the...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	NexMetals Mining Corp. - 10-Q, Quarterly Report
Do	Nexmetals Mining Corp (2): Nexmetals files final prospectus
Do	NexMetals Mining Corp.: NexMetals Announces Filing of Final Short Form Prospectus	Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) (the "Company" or "NEXM") is pleased to announce that it has filed a final short... ► Artikel lesen
07.11.	NexMetals Mining-Aktie: Unbeachtete Chance?	Die NexMetals Mining-Aktie könnte jetzt eine spannende Chance für Anleger bieten, die die Börse bisher ignoriert hat. Das ist jetzt wichtig zu wissen: Anleger übersehen Chancen Es ist nicht ungewöhnlich... ► Artikel lesen
31.10.	Nexmetals Mining Corp (2): Nexmetals increases public offering to $80-million

Zeit

Aktuelle Nachrichten

NexMetals Mining Corp. - 10-Q, Quarterly Report

Nexmetals Mining Corp (2): Nexmetals files final prospectus

NexMetals Mining Corp.: NexMetals Announces Filing of Final Short Form Prospectus

Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) (the "Company" or "NEXM") is pleased to announce that it has filed a final short...
► Artikel lesen

07.11.

NexMetals Mining-Aktie: Unbeachtete Chance?

Die NexMetals Mining-Aktie könnte jetzt eine spannende Chance für Anleger bieten, die die Börse bisher ignoriert hat. Das ist jetzt wichtig zu wissen: Anleger übersehen Chancen Es ist nicht ungewöhnlich...
► Artikel lesen

31.10.

Nexmetals Mining Corp (2): Nexmetals increases public offering to $80-million

Zeit	Aktuelle Nachrichten
Di	Nordic Technology Group AS: MossHydro AS secures a NOK 1.2 million commercial contract with delivery of filter for wellboat
30.08.	Nordic Technology Group AS: NTG: 1H 2025 report
16.07.	XFRA DELETION OF INSTRUMENTS FROM XETRA - 16.07.2025	The following instruments on XETRA do have their last trading day on 16.07.2025Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 16.07.2025ISIN NameDE000HLB0908 LB.HESS.-THR.IS.15/25CH0021894602... ► Artikel lesen
09.07.	Nordic Technology Group AS Registered share capital increase
02.07.	Nordic Technology Group AS Registered share capital increase

Zeit

Aktuelle Nachrichten

Nordic Technology Group AS: MossHydro AS secures a NOK 1.2 million commercial contract with delivery of filter for wellboat

30.08.

Nordic Technology Group AS: NTG: 1H 2025 report

16.07.

XFRA DELETION OF INSTRUMENTS FROM XETRA - 16.07.2025

The following instruments on XETRA do have their last trading day on 16.07.2025Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 16.07.2025ISIN NameDE000HLB0908 LB.HESS.-THR.IS.15/25CH0021894602...
► Artikel lesen

09.07.

Nordic Technology Group AS Registered share capital increase

02.07.

Nordic Technology Group AS Registered share capital increase

Zeit	Aktuelle Nachrichten
21.10.	Qliro AB Q3 Loss Increases
21.10.	Qliro AB: Qliro AB publishes Interim Report for Q3 2025: Accelerating commercial momentum, aiming for profitability in Q1 2026	Third quarter 2025 (Third quarter 2024)• Total payment volume increased by 50% to SEK 4,379 (2,922) million• Operating income increased by 3% to SEK 99.2 (96.1) million• Adjusted operating expenses... ► Artikel lesen
14.10.	Qliro AB: Qliro appoints Christofer Zetterquist as interim CFO	Qliro AB (publ) today announces that Christofer Zetterquist has been appointed interim CFO. He assumes the role immediately, succeeding Carl Löfgren, who announced his decision to step down as CFO in... ► Artikel lesen
22.09.	Qliro AB: Qliro aims for profitability in Q1 2026 with continued growth acceleration and streamlined organization	Qliro AB (publ) ("Qliro" or "the Company") today announced organizational changes designed to improve efficiency, scalability and growth capacity. When fully implemented, the changes in combination... ► Artikel lesen
01.09.	Qliro AB: Carl Löfgren leaves the position as CFO of Qliro	Qliro AB (publ) ("Qliro" or the "Company") announces today that the Company's CFO, Carl Löfgren, has decided to leave his position at Qliro at his own request. Carl will remain in his role until a successor... ► Artikel lesen

Zeit

Aktuelle Nachrichten

21.10.

Qliro AB Q3 Loss Increases

21.10.

Qliro AB: Qliro AB publishes Interim Report for Q3 2025: Accelerating commercial momentum, aiming for profitability in Q1 2026

Third quarter 2025 (Third quarter 2024)• Total payment volume increased by 50% to SEK 4,379 (2,922) million• Operating income increased by 3% to SEK 99.2 (96.1) million• Adjusted operating expenses...
► Artikel lesen

14.10.

Qliro AB: Qliro appoints Christofer Zetterquist as interim CFO

Qliro AB (publ) today announces that Christofer Zetterquist has been appointed interim CFO. He assumes the role immediately, succeeding Carl Löfgren, who announced his decision to step down as CFO in...
► Artikel lesen

22.09.

Qliro AB: Qliro aims for profitability in Q1 2026 with continued growth acceleration and streamlined organization

Qliro AB (publ) ("Qliro" or "the Company") today announced organizational changes designed to improve efficiency, scalability and growth capacity. When fully implemented, the changes in combination...
► Artikel lesen

01.09.

Qliro AB: Carl Löfgren leaves the position as CFO of Qliro

Qliro AB (publ) ("Qliro" or the "Company") announces today that the Company's CFO, Carl Löfgren, has decided to leave his position at Qliro at his own request. Carl will remain in his role until a successor...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	Rosebank Industries - Appointment of Non-Executive Director
31.10.	Broker tips: Rosebank Industries, Kingfisher, Grafton
31.10.	Citi starts coverage of Rosebank Industries at 'buy'
09.09.	Barclays initiates Rosebank Industries stock with Overweight rating
09.09.	Barclays startet Coverage für Rosebank Industries mit "Overweight"

Zeit

Aktuelle Nachrichten

Rosebank Industries - Appointment of Non-Executive Director

31.10.

Broker tips: Rosebank Industries, Kingfisher, Grafton

31.10.

Citi starts coverage of Rosebank Industries at 'buy'

09.09.

Barclays initiates Rosebank Industries stock with Overweight rating

09.09.

Barclays startet Coverage für Rosebank Industries mit "Overweight"

Zeit	Aktuelle Nachrichten
30.10.	Rottneros meldet Verlust für Q3 2025 angesichts schwieriger Marktbedingungen
30.10.	Rottneros AB: Rottneros' interim report January-September 2025	Lower turnover and profit in a challenging marketNET TURNOVER dropped by 16 percent to 574 (685) MSEK. The weak CTMP market resulted in lower sales volumes. At the same time, selling prices denominated... ► Artikel lesen
16.10.	Nomination Committee appointed for AGM 2026 in Rottneros AB (publ)
06.10.	Rottneros extends partnership with AtoB@C Shipping to cut CO2 emissions on Vallvik routes
02.10.	AtoB@C Shipping: New plug-in hybrid vessel to work for Rottneros

Zeit

Aktuelle Nachrichten

30.10.

Rottneros meldet Verlust für Q3 2025 angesichts schwieriger Marktbedingungen

30.10.

Rottneros AB: Rottneros' interim report January-September 2025

Lower turnover and profit in a challenging marketNET TURNOVER dropped by 16 percent to 574 (685) MSEK. The weak CTMP market resulted in lower sales volumes. At the same time, selling prices denominated...
► Artikel lesen

16.10.

Nomination Committee appointed for AGM 2026 in Rottneros AB (publ)

06.10.

Rottneros extends partnership with AtoB@C Shipping to cut CO2 emissions on Vallvik routes

02.10.

AtoB@C Shipping: New plug-in hybrid vessel to work for Rottneros

Unternehmen / Aktien	Kurs	%
ISOFOL MEDICAL AB	0,047	-2,11 %
NEXMETALS MINING CORP	3,160	-3,66 %
NORDIC TECHNOLOGY GROUP AS	0,050	0,00 %
QLIRO AB	1,580	-1,56 %
ROSEBANK INDUSTRIES PLC	3,740	-4,10 %
ROTTNEROS AB	0,184	-3,46 %

Unternehmen / Aktien

Kurs

ISOFOL MEDICAL AB

0,047

-2,11 %

NEXMETALS MINING CORP

3,160

-3,66 %

NORDIC TECHNOLOGY GROUP AS

0,050

0,00 %

QLIRO AB